Broker Research
July 29, 2025 / 12:53 IST
Reported Consolidated quarterly numbers for Astec Lifesciences are:Net Sales at Rs 91.08 crore in June 2025 up 31.29% from Rs. 69.37 crore in June 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 33.04 crore in June 2025 up 16.83% from Rs. 39.72 crore in June 2024.
EBITDA stands negative at Rs. 10.48 crore in June 2025 up 76.88% from Rs. 45.33 crore in June 2024.
Astec Life shares closed at 863.20 on July 25, 2025 (NSE) and has given -11.54% returns over the last 6 months and -31.87% over the last 12 months.
Astec Lifesciences | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'25 | Mar'25 | Jun'24 | Net Sales/Income from operations | 91.08 | 119.53 | 69.37 | Other Operating Income | -- | -- | -- | Total Income From Operations | 91.08 | 119.53 | 69.37 | EXPENDITURE | Consumption of Raw Materials | 59.41 | 85.45 | 33.71 | Purchase of Traded Goods | -- | -- | -- | Increase/Decrease in Stocks | 4.48 | -11.92 | 47.88 | Power & Fuel | -- | -- | -- | Employees Cost | 15.18 | 14.43 | 16.23 | Depreciation | 11.49 | 11.58 | 9.27 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 23.00 | 26.04 | 17.81 | P/L Before Other Inc., Int., Excpt. Items & Tax | -22.48 | -6.05 | -55.52 | Other Income | 0.51 | 0.79 | 0.92 | P/L Before Int., Excpt. Items & Tax | -21.97 | -5.26 | -54.60 | Interest | 11.04 | 10.40 | 7.04 | P/L Before Exceptional Items & Tax | -33.02 | -15.66 | -61.64 | Exceptional Items | -- | -- | -- | P/L Before Tax | -33.02 | -15.66 | -61.64 | Tax | 0.01 | 0.42 | -21.92 | P/L After Tax from Ordinary Activities | -33.03 | -16.08 | -39.72 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -33.03 | -16.08 | -39.72 | Minority Interest | -0.01 | -0.01 | -0.01 | Share Of P/L Of Associates | -- | -- | -- | Net P/L After M.I & Associates | -33.04 | -16.09 | -39.72 | Equity Share Capital | 19.61 | 19.61 | 19.61 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -16.85 | -8.20 | -20.26 | Diluted EPS | -16.85 | -8.20 | -20.26 | EPS After Extra Ordinary | Basic EPS | -16.85 | -8.20 | -20.26 | Diluted EPS | -16.85 | -8.20 | -20.26 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!